FDA Advisory Committee Recommends Approval of Paratek’s Omadacycline
Go back to FDA Advisory Committee Recommends Approval of Paratek’s Omadacycline| Profile Technologies, Inc. (NASDAQ: PRTK) | Delayed: 2.23 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.23 | 52 Week High | $22.00 | |||
| Open | $0.00 | 52 Week Low | $9.80 | |||
| Day High | $2.23 | P/E | N/A | |||
| Day Low | $2.23 | EPS | $-0.08 | |||
| Volume | 1,940,343 | |||||
| (NASDAQ: ZLAB) | Delayed: 23.32 +2.44 (11.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.88 | 52 Week High | $ | |||
| Open | $21.96 | 52 Week Low | $ | |||
| Day High | $24.07 | P/E | N/A | |||
| Day Low | $21.58 | EPS | $ | |||
| Volume | 2,046,149 | |||||
